Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma news

    Tag: pharma news

    You Searched For "pharma news"
    Novartis sickle cell drug crizanlizumab secures speedy USFDA review

    Novartis sickle cell drug crizanlizumab secures speedy USFDA review

    Medical Dialogues Bureau17 July 2019 9:26 AM IST
    Novartis submitted the application for crizanlizumab for the prevention of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD) and...
    USFDA issues warning letter to Indoco Remedies for Goa plant

    USFDA issues warning letter to Indoco Remedies for Goa plant

    Medical Dialogues Bureau16 July 2019 11:39 AM IST
    The facility had received six observations in Form 483s and was classified as Official Action Indicated in March. Indoco Remedies responded to these...
    Natco Pharma gets zero USFDA observations for Chennai facility

    Natco Pharma gets zero USFDA observations for Chennai facility

    Medical Dialogues Bureau16 July 2019 9:30 AM IST
    Natco Pharma announced "successful completion of regulatory inspection from the US Food and Drug Administration (USFDA) for its active pharmaceutical...
    Cancer Drug Patent Issues: Delhi HC junks Bayer plea to block Natco Pharma Regonat

    Cancer Drug Patent Issues: Delhi HC junks Bayer plea to block Natco Pharma Regonat

    Farhat Nasim15 July 2019 2:52 PM IST
    New Delhi: The Delhi High Court recently junked the injunction petition filed by the German Drugmaker to restrain the Hyderabad-based Natco Pharma...
    Sun Pharma unveils Ezallor Sprinkle capsules for treating lipid disorder in US

    Sun Pharma unveils Ezallor Sprinkle capsules for treating lipid disorder in US

    Farhat Nasim15 July 2019 2:40 PM IST
    Ezallor Sprinkle (rosuvastatin) capsules are indicated for three types of lipid disorders in conjunction with diet in adults, Sun Pharma said in a...
    Lupin to focus on launch of biosimilar, inhalation product in US this fiscal

    Lupin to focus on launch of biosimilar, inhalation product in US this fiscal

    Medical Dialogues Bureau15 July 2019 9:45 AM IST
    Coupling this with the building of Solosec brand in the US, NaMuscla in Europe and Bipresso in Japan will help Lupin drive sustainable growth, they...
    Gilead to raise stake in Belgian Biotech Galapagos in USD 5.1 billion deal: Report

    Gilead to raise stake in Belgian Biotech Galapagos in USD 5.1 billion deal: Report

    Medical Dialogues Bureau15 July 2019 9:30 AM IST
    The deal is the largest Gilead has executed since new Chief Executive Officer Dan O'Day took the reins in March as he attempts to bolster the San...
    Biocon Chief Kiran Mazumdar Shaw, husband donate over Rs 51 crore to University of Glasgow

    Biocon Chief Kiran Mazumdar Shaw, husband donate over Rs 51 crore to University of Glasgow

    Medical Dialogues Bureau13 July 2019 12:55 PM IST
    A further donation of USD 2.5 million will go towards creating a new Professorial Chair to be named the Mazumdar-Shaw Chair of Precision Oncology....
    Sandoz launches SYMJEPI Injection in US to help treat allergic reactions

    Sandoz launches SYMJEPI Injection in US to help treat allergic reactions

    Medical Dialogues Bureau13 July 2019 9:32 AM IST
    SYMJEPI is a small, single-dose, pre-filled syringe and device combination as an alternative to epinephrine auto-injectors for the emergency treatment...
    FIRST: Intas Pharma launches Romiplostim to treat chronic ITP in India

    FIRST: Intas Pharma launches Romiplostim to treat chronic ITP in India

    Medical Dialogues Bureau12 July 2019 11:48 AM IST
    Romiplostim is one of the most efficacious agents with proven long-term benefits in chronic ITP, a release here said.Mumbai: Pharma Major, Intas...
    Gilead Sciences chooses Chengdu Hi-tech Zone for Western China Operation Center project

    Gilead Sciences chooses Chengdu Hi-tech Zone for Western China Operation Center project

    Medical Dialogues Bureau12 July 2019 9:10 AM IST
    Established in 1987 and headquartered in California, Gilead Sciences is one of the top 10 pharmaceutical companies in the world. As a pioneer in...
    Trump administration scraps key plan to reduce US drug prices

    Trump administration scraps key plan to reduce US drug prices

    Medical Dialogues Bureau12 July 2019 9:00 AM IST
    The decision represents a new setback to U.S. President Donald Trump's efforts to deliver on a pledge to lower drug prices for consumers before the...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok